Cargando…
Defining & assessing the quality, usability, and utilization of immunization data
BACKGROUND: High quality data are needed for decision-making at all levels of the public health system, from guiding public health activities at the local level, to informing national policy development, to monitoring the impact of global initiatives. Although a number of approaches have been develo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450010/ https://www.ncbi.nlm.nih.gov/pubmed/30947703 http://dx.doi.org/10.1186/s12889-019-6709-1 |
_version_ | 1783408970233282560 |
---|---|
author | Bloland, Peter MacNeil, Adam |
author_facet | Bloland, Peter MacNeil, Adam |
author_sort | Bloland, Peter |
collection | PubMed |
description | BACKGROUND: High quality data are needed for decision-making at all levels of the public health system, from guiding public health activities at the local level, to informing national policy development, to monitoring the impact of global initiatives. Although a number of approaches have been developed to evaluate the underlying quality of routinely collected vaccination administrative data, there remains a lack of consensus around how data quality is best defined or measured. DISCUSSION: We present a definitional framework that is intended to disentangle many of the elements that have confused discussions of vaccination data quality to date. The framework describes immunization data in terms of three key characteristics: data quality, data usability, and data utilization. The framework also offers concrete suggestions for a specific set of indicators that could be used to better understand immunization those key characteristics, including Trueness, Concurrence, Relevancy, Efficiency, Completeness, Timeliness, Integrity, Consistency, and Utilization. CONCLUSION: Being deliberate about the choice of indicators; being clear on their definitions, limitations, and methods of measurement; and describing how those indicators work together to give a more comprehensive and practical understanding of immunization data quality, usability, and use, should yield more informed, and therefore better, programmatic decision-making. |
format | Online Article Text |
id | pubmed-6450010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64500102019-04-16 Defining & assessing the quality, usability, and utilization of immunization data Bloland, Peter MacNeil, Adam BMC Public Health Debate BACKGROUND: High quality data are needed for decision-making at all levels of the public health system, from guiding public health activities at the local level, to informing national policy development, to monitoring the impact of global initiatives. Although a number of approaches have been developed to evaluate the underlying quality of routinely collected vaccination administrative data, there remains a lack of consensus around how data quality is best defined or measured. DISCUSSION: We present a definitional framework that is intended to disentangle many of the elements that have confused discussions of vaccination data quality to date. The framework describes immunization data in terms of three key characteristics: data quality, data usability, and data utilization. The framework also offers concrete suggestions for a specific set of indicators that could be used to better understand immunization those key characteristics, including Trueness, Concurrence, Relevancy, Efficiency, Completeness, Timeliness, Integrity, Consistency, and Utilization. CONCLUSION: Being deliberate about the choice of indicators; being clear on their definitions, limitations, and methods of measurement; and describing how those indicators work together to give a more comprehensive and practical understanding of immunization data quality, usability, and use, should yield more informed, and therefore better, programmatic decision-making. BioMed Central 2019-04-04 /pmc/articles/PMC6450010/ /pubmed/30947703 http://dx.doi.org/10.1186/s12889-019-6709-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate Bloland, Peter MacNeil, Adam Defining & assessing the quality, usability, and utilization of immunization data |
title | Defining & assessing the quality, usability, and utilization of immunization data |
title_full | Defining & assessing the quality, usability, and utilization of immunization data |
title_fullStr | Defining & assessing the quality, usability, and utilization of immunization data |
title_full_unstemmed | Defining & assessing the quality, usability, and utilization of immunization data |
title_short | Defining & assessing the quality, usability, and utilization of immunization data |
title_sort | defining & assessing the quality, usability, and utilization of immunization data |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450010/ https://www.ncbi.nlm.nih.gov/pubmed/30947703 http://dx.doi.org/10.1186/s12889-019-6709-1 |
work_keys_str_mv | AT blolandpeter definingassessingthequalityusabilityandutilizationofimmunizationdata AT macneiladam definingassessingthequalityusabilityandutilizationofimmunizationdata |